[1]
M. Learning Group, “The Cataylst Initiative: Innovative CME on Appropriate Use of Immunotherapy in the Systemic Treatment of Locally Advanced and Metastatic BCC and cSCC”, J of Skin, vol. 5, no. 6, p. s78, Nov. 2021.